GATA3: A multispecific but potentially useful marker in surgical pathology: A systematic analysis of 2500 epithelial and nonepithelial tumors

American Journal of Surgical Pathology

Volumn 38, Issue 1, 2014, Pages 13-22

  Miettinen, Markku ^a   McCue, Peter A ^b   Sarlomo Rikala, Maarit ^c   Rys, Janusz ^d   Czapiewski, Piotr ^e   Wazny, Krzysztof ^e   Langfort, Renata ^f   Waloszczyk, Piotr ^g   Biernat, Wojciech ^e   Lasota, Jerzy ^a   Wang, Zengfeng ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF GDANSK   (Poland)

^f NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^g Independent Laboratory of Pathology   (Poland)

Author keywords

breast cancer; choriocarcinoma; chromophobe renal carcinoma; endodermal sinus tumor; GATA3; immunohistochemistry; mesothelioma; urothelial cancer

Indexed keywords

GATA3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER;

ANIMAL EMBRYO; ARTICLE; BIOPSY; CARCINOMA; CHEMISTRY; CONNECTIVE TISSUE TUMOR; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NEUROECTODERM TUMOR; PREDICTIVE VALUE; PROGNOSIS;

BIOPSY; CARCINOMA; EMBRYO, MAMMALIAN; FEMALE; GATA3 TRANSCRIPTION FACTOR; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, CONNECTIVE TISSUE; NEUROECTODERMAL TUMORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891623727     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182a0218f     Document Type: Article

References (31)

1. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol. 2010;222:42-49.
2. Zheng R, Blobel G. GATA transcription factors and cancer. Genes Cancer. 2010;1:1178-1188.
3. Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminalcell differentiation. Nat Cell Biol. 2007;9:201-209.
4. Yagi R, Zhu J, Paul WE. An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol. 2011;23:415-420.
5. Oosterwegel M, Timmerman J, Leiden J, et al. Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev Immunol. 1992;3:1-11.
6. Kaufman CK, Zhou P, Pasolli HA, et al. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 2003; 17:2108-2122.
7. Sellheyer K, Krahl D. Expression pattern of GATA-3 in embryonic and fetal human skin suggests a role in epidermal and follicular morphogenesis. J Cutan Pathol. 2010;37:357-361.
8. Ma GT, Roth ME, Groskopf JC, et al. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. Development. 1997;124:907-914.
9. Home P, Ray S, Dutta D, et al. GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression. J Biol Chem. 2009;284:28729-28737.
10. Ralston A, Cox BJ, Nishioka N, et al. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development. 2010;137:395-403.
11. Song H, Suehiro J, Kanki Y, et al. Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J Biol Chem. 2009;284:29109-29124.
12. Van Esch H, Devriendt K. Transcription factor GATA3 and the human HDR syndrome. Cell Mol Life Sci. 2001;58:1296-1300.
13. Cimino-Mathews A, Subhawong AP, Illei PB, et al. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Hum Pathol. 2013. [Epub ahead of print].
14. Gonzalez RS, Wang UJ, Kraus T, et al. GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance. Hum Pathol. 2013;44:1065-1070.
15. Yoon NK, Maresh EL, Shen D, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol. 2010;41:1794-1801.
16. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138:57-64.
17. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31:673-680.
18. Miyamoto H, Izumi K, Yao JL, et al. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol. 2012;43:2033-2040.
19. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36: 1472-1476.
20. Gruver AM, Amin MB, Luthringer DJ, et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Ach Pathol Lab Med. 2012;13:1339-1346.
21. Esheba GE, Longacre TA, Atkins KA, et al. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Am J Surg Pathol. 2009;33:347-353.
22. Miettinen M. A simple method for generating multitissue blocks without special equipment. Appl Immunohistochem Mol Morphol. 2012;20:410-412.
23. Gulbinas A, Berberat PO, Dambrauskas Z, et al. Aberrant gata-3 expression in human pancreatic cancer. J Histochem Cytochem. 2006;54:161-169.
24. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Pathol. 2002;26: 1542-1552.
25. Stö rkel S, Steart PV, Drenckhahn D, et al. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56:237-245.
26. Stö rkel S, Pannen B, Thoenes W, et al. Intercalated cells as a probable source for the development of renal oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;56:185-189.
27. Eble JN, Hull MT. Morphologic features of renal oncocytoma: a light and electron microscopic study. Hum Pathol. 1984;15: 1054-1061.
28. Shen SS, Krishna B, Chirala R, et al. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol. 2005;18:933-940.
29. Ulbright T. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(suppl 2):WS61-WS79.
30. Nonaka D, Wang BY, Sun CCJ. A study of Phox2B and Gata3 expression in tumors of autonomic nervous system derivation (abstract). Mod Pathol. 2013;26(suppl 2):136.
31. Daigeler A, Klein-Hitpass L, Stricker I, et al. Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study. Langenbecks Arch Surg. 2010;395:261-275.